While babies born at full term after a gestation period of nine months weigh around 2.5 to 4 kg, this one was weak with ...

The FDA also granted orphan drug designation to FLQ-101 earlier in 2024. FELIQS is preparing to submit an investigational new ...

"Oak Hill Bio and Chiesi’s BPD prevention trial enrols first European subject" was originally created and published by ...

This letter was submitted in response to the column "In Corruption Case Against Eric Adams, Prosecutors Are Attempting to ...

Metabolic dysfunction-associated steatohepatitis, or MASH, is a kind of chronic liver inflammation and scarring caused by ...

Researchers evaluated the etiology, risk factors, and prevalence of recurrent pneumonia in pediatric patients using a diagnostic algorithm.

One in three US adults don’t get enough iron, which has a major effect on getting oxygen around your body. Find out how this ...

A woman who started a prematurity awareness day after her twin grandchildren were born 15 weeks early is set to host the event for the fifth time ...

Oxygen has been identified as a key element in the delay in retinal maturation and in the development of ROP. Vascular endothelial growth factor (VEGF) is an oxygen-mediated factor that is ...

FELIQS®, a clinical stage multinational biopharmaceutical company focused on the development of first-in-class small molecules targeting lipid oxidation, announced today that the U.S. Food and Drug ...

Janney Montgomery Scott LLC lessened its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.4% ...

Oak Hill Bio, Chiesi announce first European patient enrolled in phase 2b study of OHB-607 for prevention of BPD in premature infants: Parma, Italy Tuesday, November 5, 2024, 14:0 ...